Potentiation of cytotoxicity and antitumor activity of adenosine analogs by the adenosine deaminase inhibitor adecypenol.
Tanaka
H
H
School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.
Kawakami
T
T
Yang
Z B
ZB
Komiyama
K
K
Omura
S
S
D000241:Adenosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D000970:Antineoplastic Agents; D003517:Cyclopentanes / Q000494:pharmacology*; D003839:Deoxyadenosines / Q000494:pharmacology; D004357:Drug Synergism; D006367:HeLa Cells; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D015394:Molecular Structure; D009700:Nucleoside Deaminases / Q000037:antagonists & inhibitors*; D011687:Purines / Q000494:pharmacology*; D014740:Vidarabine / Q000494:pharmacology
D058892:Adenosine Deaminase Inhibitors; D000970:Antineoplastic Agents; D003517:Cyclopentanes; D003839:Deoxyadenosines; D011687:Purines; C048275:adecypenol; D009700:Nucleoside Deaminases; D014740:Vidarabine; D000241:Adenosine